Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Characterization of the molecular mechanisms controlling anti-LG3 autoantibody production in the context of lupus nephritis

EF 2021-22

Résumé
Systemic lupus erythematosus (SLE) is an autoimmune disease. One of the targeted organs is the kidney, leading to a serious condition called lupus nephritis (LN). LN affects up to 60% of patients with SLE, 30% of whom progress to end-stage renal disease. Kidneys are then unable to filter waste products from the blood. Patients must undergo dialysis or transplantation to survive.During LN, blood vessels that supply nutrients to kidneys are damaged. Biopsy is the gold-standard for assessing the condition of the kidney, but it is an invasive procedure. Our understanding of the mechanisms leading to the attack on the kidney is still very partial and the development of non-invasive methods is needed to track, treat, and prevent LN complications.Our team demonstrated that damaged blood vessels release molecular messengers. This induces the production of antibodies (Ab) against self-molecules. One of these molecules, LG3, is found on the blood vessels. Our group showed that Ab against LG3(anti-LG3) in vessels are important in the loss of microvessels in several kidney diseases. Also, anti-LG3 are found in higher amounts in the blood of LN patients as well as in mice with lupus. We hypothesize that anti-LG3 Ab contribute to damage to blood vessels and loss of kidney function in LN patients. The aim of my project is to characterize the appearance of anti-LG3 and the molecular mechanisms that control anti-LG3 Ab production as well as their renal effects in lupus mice. That will allow us to identify novel mechanisms and predictors of renal dysfunction. Our project offers an opportunity to identify new interventional targets that will help track and treat LN patients.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466917
Name
Juillard Sandrine C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of the molecular mechanisms controlling anti-LG3 autoantibody production in the context of lupus nephritis
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoptosis; Auto-Antibodies; Autoimmunity; B Lymphocytes; Biomarkers; Immunology; Inflammation; Lupus Nephritis (Ln); Systemic Lupus Erythematosus (Sle); Toll Like Receptors (Tlr)
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease. One of the targeted organs is the kidney, leading to a serious condition called lupus nephritis (LN). LN affects up to 60% of patients with SLE, 30% of whom progress to end-stage renal disease. Kidneys are then unable to filter waste products from the blood. Patients must undergo dialysis or transplantation to survive.During LN, blood vessels that supply nutrients to kidneys are damaged. Biopsy is the gold-standard for assessing the condition of the kidney, but it is an invasive procedure. Our understanding of the mechanisms leading to the attack on the kidney is still very partial and the development of non-invasive methods is needed to track, treat, and prevent LN complications.Our team demonstrated that damaged blood vessels release molecular messengers. This induces the production of antibodies (Ab) against self-molecules. One of these molecules, LG3, is found on the blood vessels. Our group showed that Ab against LG3(anti-LG3) in vessels are important in the loss of microvessels in several kidney diseases. Also, anti-LG3 are found in higher amounts in the blood of LN patients as well as in mice with lupus. We hypothesize that anti-LG3 Ab contribute to damage to blood vessels and loss of kidney function in LN patients. The aim of my project is to characterize the appearance of anti-LG3 and the molecular mechanisms that control anti-LG3 Ab production as well as their renal effects in lupus mice. That will allow us to identify novel mechanisms and predictors of renal dysfunction. Our project offers an opportunity to identify new interventional targets that will help track and treat LN patients.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Juillard, Sandrine C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~